Dr. Erik Roberson
Dr. Roberson is an Associate Professor of Neurology and Neurobiology and Co-Director of the Center for Neurodegeneration and Experimental Therapeutics at the University of Alabama at Birmingham (UAB). He received his A.B. with highest honors from Princeton University and then earned his M.D. and Ph.D in neuroscience at Baylor College of Medicine where he studied molecular mechanisms of learning and memory. He completed a residency in neurology at the University of California San Francisco, where he also served as Chief Resident in Neurology. After residency, he completed a clinical fellowship in behavioral neurology with Dr. Bruce Miller at UCSF and resumed basic research in the laboratory of Dr. Lennart Mucke at the Gladstone Institute of Neurological Disease, initiating his current studies of neurodegenerative disease using mouse models. He joined the neurology faculty at UCSF in 2005 and moved to UAB in 2008.
The Roberson lab studies the neurobiology of Alzheimer’s disease (AD) and frontotemporal dementia (FTD), with a focus on understanding the cellular and molecular mechanisms of these disorders and identifying new therapeutic strategies. The role of tau in neuronal dysfunction in AD and FTD is a major area of interest, and the lab also studies how progranulin deficiency causes FTD.
In addition to directing his laboratory, Dr. Roberson is Co-Director of the Center for Neurodegeneration and Experimental Therapeutics, which is dedicated to developing new therapies for age-related cognitive disorders and neurodegenerative disease. Dr. Roberson also cares for patients with memory disorders and dementia at the Kirklin Clinic and directs clinical trials related to tauopathies.
2015 Erik Roberson Advisor Fellow: Dr. Travis Rush, Targeting the Tau-Fyn Interaction in Alzheimer’s Disease
2016 Erik Roberson Advisor Fellow: Dr. Travis Rush, Targeting the Tau-Fyn Interaction in Alzheimer’s Disease